Tanner Health and Healthliant Ventures partner with Optellum to launch an artificial intelligence (AI) platform designed to detect lung cancer.

Man’s best friend may become cancer’s worst enemy.

Researchers have identified a 14-protein blood signature that may predict lung cancer risk up to five years before diagnosis, ...

Researchers identified a 14-protein blood signature that may predict lung cancer years early, potentially enabling earlier ...

Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before ...

OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...

New patent expands globally protected IP estate beyond blood into alternative biofluids, positioning the Company's clinical mass spectrometry platform against traditional genomic liquid biopsies.

As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start a tumor. An ...